This enhancement suggests that the PKA phosphorylation pathway is activated through TRPV1 signaling, further underscoring the therapeutic potential of CAP in combating endothelial dysfunction caused by hyperglycemia [12]. This evidence concerns the gene TRPV1 and endothelial dysfunction.